Stock data
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX) reported revenue of US$726.41M and net income of US$7.03M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$726.41M | — | US$19.19M | US$7.03M | — |
| 2024 | US$700.97M | — | -US$73.37M | -US$99.56M | — |
| 2023 | US$674.98M | — | US$87.67M | US$41.95M | — |
| 2022 | US$666.82M | — | US$60.02M | US$15.91M | — |
| 2021 | US$541.53M | — | US$89.92M | US$41.98M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$192.40M | US$4.65M | — |
| 2026-03-31 | US$177.38M | US$2.92M | — |
| 2025-12-31 | US$196.87M | US$1.64M | — |
| 2025-09-30 | US$179.52M | US$5.43M | — |
| 2025-06-30 | US$181.10M | -US$4.85M | — |
| 2025-03-31 | US$168.92M | US$4.81M | — |
| 2024-12-31 | US$187.25M | US$16.04M | — |
| 2024-09-30 | US$168.57M | -US$143.47M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.